These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34698529)

  • 1. Transthyretin Suppressed Tumor Progression in Nonsmall Cell Lung Cancer by Inactivating MAPK/ERK Pathway.
    Wang DB; Li X; Lu XK; Sun ZY; Zhang X; Chen X; Ma L; Xia HG
    Cancer Biother Radiopharm; 2021 Oct; ():. PubMed ID: 34698529
    [No Abstract]   [Full Text] [Related]  

  • 2. EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells.
    Gao L; Yang T; Zhang S; Liang Y; Shi P; Ren H; Hou P; Chen M
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
    Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
    Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
    Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells.
    Tang W; Jia P; Zuo L; Zhao J
    Cell Cycle; 2022 Aug; 21(16):1697-1709. PubMed ID: 35485293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
    Wang Q; Wu H; Wu Q; Zhong S
    Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calotropin regulates the apoptosis of non‑small cell cancer by regulating the cytotoxic T‑lymphocyte associated antigen 4‑mediated TGF‑β/ERK signaling pathway.
    Tian L; Xie XH; Zhu ZH
    Mol Med Rep; 2018 Jun; 17(6):7683-7691. PubMed ID: 29620207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA SDPR-AS affects the development of non-small cell lung cancer by regulating SDPR through p38 MAPK/ERK signals.
    Zhu J; Wang L; Liao R
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3172-3179. PubMed ID: 31352804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway.
    Li C; Fan S; Owonikoko TK; Khuri FR; Sun SY; Li R
    Oncogene; 2011 Sep; 30(35):3802-12. PubMed ID: 21478903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
    Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
    Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
    Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
    Shi H; Bi H; Sun X; Dong H; Jiang Y; Mu H; Liu G; Kong W; Gao R; Su J
    Mol Med Rep; 2018 Mar; 17(3):4327-4336. PubMed ID: 29363720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.
    Zhang B; Tao F; Zhang H
    Mol Med Rep; 2018 Apr; 17(4):4899-4908. PubMed ID: 29393472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Expression Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer via ERK/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.
    Liu C; Li H; Jia J; Ruan X; Liu Y; Zhang X
    Med Sci Monit; 2019 Jul; 25():5143-5149. PubMed ID: 31293277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of
    Zhang P; Li Z; Yang G
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.